A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain
Clinical trial NCT05838755 · TERMINATED
Trial details
- NCT number
- NCT05838755
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-20
- Primary completion
- 2024-10-14
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.